日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01

一项关于泼尼松与地塞米松治疗急性淋巴细胞白血病的随机试验的神经心理学结果:来自丹娜-法伯癌症研究所所有联盟方案00-01的研究结果

Waber, Deborah P; McCabe, Marie; Sebree, Mikaela; Forbes, Peter W; Adams, Heather; Alyman, Cheryl; Sands, Stephen A; Robaey, Philippe; Romero, Ivonne; Routhier, Marie-Ève; Girard, Jonathan M; Sallan, Stephen E; Silverman, Lewis B

Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis

采用 Dana-Farber ALL 联盟 95-01 方案治疗急性淋巴细胞白血病的标准风险和高风险患者在诊断后 5 年的神经心理学结果

Waber, Deborah P; Queally, Jennifer Turek; Catania, Lori; Robaey, Philippe; Romero, Ivonne; Adams, Heather; Alyman, Cheryl; Jandet-Brunet, Christine; Sallan, Stephen E; Silverman, Lewis B

Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

儿童急性淋巴细胞白血病积极治疗期间皮质类固醇的神经行为副作用与年龄相关:来自丹娜-法伯癌症研究所ALL联盟方案00-01的报告

Mrakotsky, Christine M; Silverman, Lewis B; Dahlberg, Suzanne E; Alyman, M Cheryl A; Sands, Stephen A; Queally, Jennifer T; Miller, Tamara P; Cranston, Amy; Neuberg, Donna S; Sallan, Stephen E; Waber, Deborah P